On Friday, Arcellx Inc (NASDAQ: ACLX) opened higher 3.09% from the last session, before settling in for the closing price of $71.86. Price fluctuations for ACLX have ranged from $47.86 to $107.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -31.14% over the past five years. Company’s average yearly earnings per share was noted -97.42% at the time writing. With a float of $39.73 million, this company’s outstanding shares have now reached $55.37 million.
Let’s look at the performance matrix of the company that is accounted for 163 employees. In terms of profitability, gross margin is 97.16%, operating margin of -376.26%, and the pretax margin is -326.84%.
Arcellx Inc (ACLX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arcellx Inc is 28.33%, while institutional ownership is 84.84%. The most recent insider transaction that took place on Jun 10 ’25, was worth 101,040. In this transaction Director of this company sold 1,500 shares at a rate of $67.36, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’25, when Company’s Director proposed sale 1,500 for $66.86, making the entire transaction worth $100,290.
Arcellx Inc (ACLX) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.48 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.24) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.88 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -97.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.89% during the next five years compared to -31.14% drop over the previous five years of trading.
Arcellx Inc (NASDAQ: ACLX) Trading Performance Indicators
Check out the current performance indicators for Arcellx Inc (ACLX). In the past quarter, the stock posted a quick ratio of 3.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 72.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.41, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.26 in one year’s time.
Technical Analysis of Arcellx Inc (ACLX)
Arcellx Inc (NASDAQ: ACLX) saw its 5-day average volume 0.69 million, a positive change from its year-to-date volume of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 69.42%.
During the past 100 days, Arcellx Inc’s (ACLX) raw stochastic average was set at 97.04%, which indicates a significant increase from 90.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.40 in the past 14 days, which was lower than the 3.45 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $68.21, while its 200-day Moving Average is $70.67. Nevertheless, the first resistance level for the watch stands at $75.13 in the near term. At $76.17, the stock is likely to face the second major resistance level. The third major resistance level sits at $78.15. If the price goes on to break the first support level at $72.11, it is likely to go to the next support level at $70.13. The third support level lies at $69.09 if the price breaches the second support level.
Arcellx Inc (NASDAQ: ACLX) Key Stats
There are currently 55,459K shares outstanding in the company with a market cap of 4.11 billion. Presently, the company’s annual sales total 107,940 K according to its annual income of -107,350 K. Last quarter, the company’s sales amounted to 7,550 K and its income totaled -52,770 K.
